What can we learn from Hamza's case?
Early suspicion of fungal infection is
key for successful treatment13
A number of factors lead to treatment delays,
increasing the risk of mortality, including poor
clinical suspicion of fungal infections and their
identifiable risk factors, access to modern
diagnostic tools (in developing countries) and
lengthy diagnostic processes.13,14
Consider Liposomal Amphotericin B
treatment for Aspergillus infections7–10
Liposomal Amphotericin B was a suitable treatment
choice, as it is fungicidal against the majority of
clinically relevant Aspergillus species.7,8,10,15,16
Be alert to high mortality risk of invasive
tracheobronchitis16
Invasive tracheobronchitis carries a very high
mortality rate in comparison with other pulmonary
forms of influenza-associated pulmonary
aspergillosis.17
Suspect early, treat promptly and broad to
help reduce risk of IFI mortality.4,13,14,17–21
Early suspicion of fungal infection is key for
successful treatment13
Be alert to high mortality risk of invasive
tracheobronchitis16
Suspect early, treat promptly and broad to
help reduce risk of IFI mortality.4,13,14,17–21
Consider Liposomal Amphotericin B treatment for
Aspergillus infections7–10
A number of factors lead to treatment delays, increasing the
risk of mortality, including poor clinical suspicion of fungal
infections and their identifiable risk factors, access to modern
diagnostic tools (in developing countries) and lengthy diagnostic
processes.13,14
Invasive tracheobronchitis carries a very high mortality
rate in comparison with other pulmonary forms of
influenza-associated pulmonary aspergillosis.17
Liposomal Amphotericin B was a suitable treatment choice,
as it is fungicidal against the majority of clinically relevant
Aspergillus species.7,8,10,15,16
What can we learn from Hamza's case?